drugset / Trial / NCT00568971

Study of Weekly DCF to Treat Advanced Gastric Cancer

NCT00568971 ↗

Phase 2 Terminated 40 enrolled Fudan University
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the efficacy of weekly docetaxol combined with cisplatin and 5-Fu in patients with AGC.

Timeline

Start
2007-04
Primary completion
2008-06
Completion
2008-06

Outcome

Outcome not reported

Stopped: “The study has finished.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 30 mg/m2 Intravenous
Subject Docetaxel Small molecule 33.3 mg/m2 Intravenous
Subject fluorouracil Small molecule 1500 mg/m2 Intravenous

Indications